Skip to content
CTLT Catalent Inc NYSE
38.81 USD -0.49% -0.19
OPEN 39.25
DAY RANGE 40.11 - 38.48
52 WEEK RANGE 115.34 - 31.45
Interactive Brokers Logotype

Buy CTLT stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 7B
Enterprise value 11.4B
Trailing pe 16.9476
Forward pe 21.207651
Peg ratio 21.207651
Price to sales ttm 1.4692649
Price to book mrq 1.4220805
Enterprise to revenue 2.4
Enterprise to ebitda 10.371


Fiscal year ends 2022-06-30
Most recent quarter 2022-12-31
Profit margin 0.08619001
Operating margin 0.14715
Return on assets ttm 0.04098
Return on equity ttm 0.087299995
Income statement
Revenue ttm 4.8B
Revenue per share ttm 26.501
Quarterly revenue growth -0.056
Gross profit ttm 1.6B
Ebitda 1B
Net income to common ttm 407M
Diluted eps ttm 2.29
Quarterly earnings growth yoy -0.165
Balance sheet
Total cash mrq 470M
Total cash per share mrq 2.61
Total debt mrq 4.9B
Total debt to equity mrq 99.043
Current ratio mrq 1.912
Book value per share mrq 27.291
Cash flow
Operating cash flow ttm 329M
Levered free cash flow ttm -402500000

Stock statistics

Shares outstanding 180.1M
Float shares 179.3M
Avg 10 volume 3.8M
Avg 30 volume 5.7M
Shares short 6.2M
Short ratio 0.91
Short percent of shares outstanding 0.0388
Percent held by insiders 0.00366
Percent held by institutions 1.05829

Stock price summary

Fifty two week low 31.45
Fifty two week high 115.335
Fifty two week change -166.297
Beta 1.166432
Day 50 ma 44.9786
Day 200 ma 58.70255

Dividends and splits

Catalent (CTLT) company profile

Catalent Inc. (NYSE: CTLT) is a medical company that provides delivery technologies and development and manufacturing solutions for drugs, protein, cell, gene therapy biologics and consumer health products. It operates through the segments of Softgel and Oral Technologies, Biologics, Oral and Specialty Delivery, and Clinical Supply Services. Catalent also provides packaging services, labelling, storage, distribution, and inventory management for clinical drug trials.